Latest News
Health
IIIT-H study caution doctors against relying entirely on AI for medical diagnosis
The researchers find discrepancies in chest X-ray regions highlighted by vision-language models and radiologists Read…
Health
NIMHANS launches online course to train faculty as student well-being ambassadors
The initiative is among the steps towards implementing Karnataka’s student mental health policy for higher…
Sports
Football’s latest scandal inspires apathy rather than anger
That is dangerous for the game Read the full story at source →
Markets
Hexaware Technologies share price surges 12%, up for 5th consecutive session – What's next for the stock? Experts decode
Hexaware Tech share price is up 13% over the last six months, compared to a…
Markets
Tata Technologies stock jumps 30% in 6 months, up 6% today: Should you buy now? Check target, support levels
Tata Technologies shares rose 6% to ₹736.50, rebounding from recent lows as investors watched key…
Markets
R Systems International skyrockets 15% today after it was down 34% in a year — Book profit or buy more? Experts' view
R Systems International Ltd's share price is rising today following a sharp rally in the…
Markets
Anand Rathi Wealth Q2 results 2026, dividend amount announcement today: Date, time, quarterly earnings schedule
Anand Rathi Wealth is set to announce its Q2FY27 results on October 9, with its…
Markets
Vedanta shares up 4% after announcing first interim dividend for FY27 – Record date | A stock to buy? Expert view
Vedanta shares climbed nearly 4% after the company declared its first FY27 interim dividend of…
Markets
Vedanta dividend 2026 record date, payment timeline, dividend yield and history; share performance – Full details here
Vedanta dividend 2026: Anil Agarwal-led Vedanta, on Thursday, announced its first interim dividend since its…
Markets
Fortis Healthcare, Apollo Hospitals, Max, Medanta shares rise: Should investors buy after 30% cancer drug price cap?
Hospital stocks rallied after the government capped trade margins on non-scheduled anti-cancer drugs at 30%,…